| Rank | Company | Revenue | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|---|
| 1 | $97.9B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 2 | $79.7B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 3 | $66.6B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 4 | $64.4B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 5 | $63.7B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 6 | $46.6B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 7 | $15.5B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 8 | $14.7B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 9 | $12.6B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 10 | $10.9B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 11 | $9.52B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 12 | $6.13B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 13 | $5.02B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 14 | $4.80B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 15 | $4.60B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 16 | $4.14B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 17 | $3.41B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 18 | $3.15B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 19 | $3.12B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 20 | $2.54B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 21 | $1.97B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 22 | $1.67B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 23 | $1.52B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 24 | $1.33B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 25 | $1.28B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 26 | $1.14B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 27 | $1.14B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 28 | $1.10B | Healthcare | Pharmaceuticals | United States | NYSE | |
| 29 | $1.01B | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 30 | $978M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 31 | $960M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 32 | $874M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 33 | $841M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 34 | $831M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 35 | $830M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 36 | $808M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 37 | $800M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 38 | $777M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 39 | $770M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 40 | $746M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 41 | $730M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 42 | $717M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 43 | $713M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 44 | $669M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 45 | $618M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 46 | $591M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 47 | $588M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 48 | $492M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 49 | $464M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 50 | $462M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 51 | $457M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 52 | $451M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 53 | $451M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 54 | $440M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 55 | $394M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 56 | $389M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 57 | $388M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 58 | $335M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 59 | $317M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 60 | $316M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 61 | $312M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 62 | $291M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 63 | $282M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 64 | $277M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 65 | $276M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 66 | $259M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 67 | $252M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 68 | $240M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 69 | $240M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 70 | $234M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 71 | $231M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 72 | $219M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 73 | $216M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 74 | $209M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 75 | $189M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 76 | $186M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 77 | $182M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 78 | $170M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 79 | $168M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 80 | $151M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 81 | $147M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 82 | $136M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 83 | $119M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 84 | $117M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 85 | $117M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 86 | $106M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 87 | $105M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 88 | $105M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 89 | $98.8M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 90 | $98.3M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 91 | $87.5M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 92 | $85.7M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 93 | $84.6M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 94 | $79.6M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 95 | $77.2M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 96 | $74.8M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 97 | $71.1M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 98 | $69.4M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 99 | $68.5M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 100 | $68.2M | Healthcare | Pharmaceuticals | United States | Nasdaq |